GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indo Global Exchange(s) Pte Ltd (OTCPK:IGEX) » Definitions » EBIT

Indo Global Exchange(s) Pte (Indo Global Exchange(s) Pte) EBIT : $0.00 Mil (TTM As of Oct. 2017)


View and export this data going back to 2009. Start your Free Trial

What is Indo Global Exchange(s) Pte EBIT?

Indo Global Exchange(s) Pte's earnings before interest and taxes (EBIT) for the three months ended in Oct. 2017 was $0.00 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Oct. 2017 was $0.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Indo Global Exchange(s) Pte's annualized ROC % for the quarter that ended in Oct. 2017 was 0.00%. Indo Global Exchange(s) Pte's annualized ROC (Joel Greenblatt) % for the quarter that ended in Oct. 2017 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Indo Global Exchange(s) Pte's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Oct. 2017 was 0.12%.

Indo Global Exchange(s) Pte EBIT Historical Data

The historical data trend for Indo Global Exchange(s) Pte's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indo Global Exchange(s) Pte EBIT Chart

Indo Global Exchange(s) Pte Annual Data
Trend Jul08 Jul09 Jul10 Jul11 Jul12 Jul13 Jul14 Jul15 Jul16 Jul17
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.04 -0.42 -3.00 -2.45 -

Indo Global Exchange(s) Pte Quarterly Data
Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Indo Global Exchange(s) Pte's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Indo Global Exchange(s) Pte's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Indo Global Exchange(s) Pte's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Indo Global Exchange(s) Pte's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Indo Global Exchange(s) Pte's EV-to-EBIT falls into.


Indo Global Exchange(s) Pte EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Oct. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo Global Exchange(s) Pte  (OTCPK:IGEX) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Indo Global Exchange(s) Pte's annualized ROC % for the quarter that ended in Oct. 2017 is calculated as:

ROC % (Q: Oct. 2017 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jul. 2017 ) + Invested Capital (Q: Oct. 2017 ))/ count )
=0 * ( 1 - 0% )/( (0.136 + 0.136)/ 2 )
=0/0.136
=0.00 %

where

Invested Capital(Q: Jul. 2017 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0 - 0.351 - ( 0 - max(0, 0.487 - 0+0))
=0.136

Invested Capital(Q: Oct. 2017 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0 - 0.351 - ( 0 - max(0, 0.487 - 0+0))
=0.136

Note: The Operating Income data used here is four times the quarterly (Oct. 2017) data.

2. Joel Greenblatt's definition of Return on Capital:

Indo Global Exchange(s) Pte's annualized ROC (Joel Greenblatt) % for the quarter that ended in Oct. 2017 is calculated as:

ROC (Joel Greenblatt) %(Q: Oct. 2017 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jul. 2017  Q: Oct. 2017
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=0/( ( (0 + max(-0.351, 0)) + (0 + max(-0.351, 0)) )/ 1 )
=0/( ( 0 + 0 )/ 1 )
=0/0
= %

where Working Capital is:

Working Capital(Q: Jul. 2017 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.351 + 0 + 0)
=-0.351

Working Capital(Q: Oct. 2017 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0.351 + 0 + 0)
=-0.351

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Oct. 2017) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Indo Global Exchange(s) Pte's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Oct. 2017 )
=0.003/2.501
=0.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo Global Exchange(s) Pte EBIT Related Terms

Thank you for viewing the detailed overview of Indo Global Exchange(s) Pte's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Indo Global Exchange(s) Pte (Indo Global Exchange(s) Pte) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indo Global Exchange(s) Pte Ltd (OTCPK:IGEX) » Definitions » EBIT
Comparable Companies
PHIL AAMTF QMCI DIGAF GAHC IFMI PNPFF GOPH MNTR FGCO TST NHLD FBRC CSGGF SIEB CURN JMP AMRK CFLSF AC
Traded in Other Exchanges
N/A
Address
6400 S. Fiddlers Green, No. 250 No.1012, Greenwood Village, CO, USA, 80111
Website
https://www.indogloex.com
Indo Global Exchange(s) Pte Ltd is a holding company. The company is focusing on developing assets within the pharmaceutical and nutraceutical industries.